Dynamics of bacterial community development in the reef coral <em>Acropora muricata</em> following experimental antibiotic treatment by Sweet MJ et al.
Newcastle University e-prints  
Date deposited:  16th January 2012 
Version of file:  Author final 
Peer Review Status: Peer reviewed 
Citation for item: 
Sweet MJ, Croquer A, Bythell JC. Dynamics of bacterial community development in the reef 
coral Acropora muricata following experimental antibiotic treatment. Coral Reefs 2011, 30(4), 
1121-1133. 
Further information on publisher website: 
http://www.springerlink.com 
Publisher’s copyright statement: 
An author may self-archive an author-created version of his/her article on his/her own website and or in 
his/her institutional repository. 
The final publication is available at www.springerlink.com  
The definitive version of this article is available at: 
http://dx.doi.org/10.1007/s00338-011-0800-0 
Always use the definitive version when citing.   
Use Policy: 
The full-text may be used and/or reproduced and given to third parties in any format or medium, 
without prior permission or charge, for personal research or study, educational, or not for profit 
purposes provided that: 
• A full bibliographic reference is made to the original source 
• A link is made to the metadata record in Newcastle E-prints 
• The full text is not changed in any way. 
The full-text must not be sold in any format or medium without the formal permission of the 
copyright holders. 
 
 
 
Robinson Library, University of Newcastle upon Tyne, Newcastle upon Tyne.  
NE1 7RU.  Tel. 0191 222 6000 
 1 
Dynamics of bacterial community development 1 
in the reef coral Acropora muricata following 2 
experimental antibiotic treatment  3 
 4 
M.J. Sweet
1*
, A. Croquer
1,2
, J.C. Bythell
1
 5 
 6 
 7 
1. School of Biology, Ridley Building, Newcastle University, Newcastle upon Tyne 8 
NE1 7RU, UK 9 
 10 
2. Universidad Simon Bolivar, Departamento de Estudios Ambientales. Apartado 11 
postal 89000, Caracas 1080, Venezuela.  12 
 13 
1
* m.j.sweet@newcastle.ac.uk,  14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
 2 
ABSTRACT: Development of the bacterial community associated with the coral Acropora muricata (= 1 
formosa) was monitored using 16S rRNA gene-based techniques and abundance counts over time 2 
following experimental modification of the existing microbial community using the antibiotic 3 
ciprofloxacin. Abundance of bacteria was reduced >99% by the treatment, resulting in significant 4 
changes in bacterial community structure. Following redeployment to their natural environment, some 5 
settlement and re-growth of bacteria took place within a few hours, including ribosomal types that were 6 
not present, or in low abundance, in the natural microbiota. However, complete recovery of the 7 
bacterial community required longer than 96 h, which indicates a relatively slow settlement and growth 8 
of bacteria from the water column and suggests that turnover of the natural community is similarly 9 
slow. The early developing community was dominated by antibiotic-resistant bacteria from the natural 10 
microbiota that survived the treatment and proliferated in the absence of natural competitors, but also 11 
included some non-resident ribotypes colonizing from the water column. Almost all these opportunists 12 
were significantly reduced or eliminated within 96 h after treatment, demonstrating a high resilience in 13 
the natural bacterial community. Potential pathogens including a Clostridium sp. inhabited the coral at 14 
low abundances, only becoming prevalent when the natural microbiota was disturbed by the treatment. 15 
The healthy coral-associated microbiota appears to be strongly controlled by microbial interactions.  16 
 17 
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INTRODUCTION 1 
 2 
During the past few decades there have been increasing reports of the 3 
detrimental effects of coral diseases in reef ecosystems. Epizootic events have 4 
reduced important reef-building coral populations across regions, representing a rapid 5 
deterioration in reef health over large spatial scales (Brandt and McManus 2009; 6 
Teplitski and Ritchie 2009). In fact, emerging coral diseases are considered one of the 7 
major threats for coral reef ecosystems worldwide in view of their wide distribution, 8 
host range and their high levels of prevalence; which have been correlated to 9 
increasing environmental stress on coral hosts and their prokaryotic and eukaryotic 10 
associates (Lecampionalsumard et al. 1995; Rosenberg et al. 2007). 11 
 12 
Corals have a variety of mechanisms of defence against invasive pathogens. The 13 
production of mucus is thought to be the first line of defence, acting as a physical 14 
barrier protecting the epithelium (Brown and Bythell 2005). Another key defence 15 
mechanism is the production of antimicrobial compounds, this process being mediated 16 
by their natural microbial community and perhaps by the coral itself (Gunthorpe and 17 
Cameron 1990; Kim 1994; Kim et al. 2000; Rohwer and Kelley 2004; Ritchie 2006; 18 
Geffen et al. 2009; Rypien and Baker 2009). Approximately 20–30% of bacterial 19 
isolates from coral species have been shown to possess antibiotic activity (Castillo et 20 
al. 2001; Ritchie 2006). Experiments conducted with coral pathogens Vibrio shiloi 21 
and V. corallilyiticus have shown that in order to cause tissue mortality, these 22 
pathogens need first to adhere to the coral’s surface, penetrate it, and then reproduce 23 
within the host (Toren et al. 1998; Kushmaro et al. 2001; Ben-Haim and Rosenberg 24 
2002). Thus, evidence suggests that the coral pathogen must ‘break down’ the natural 25 
 4 
coral defence mechanisms (Kushmaro et al. 1998). If the bacterial community 1 
associated with the coral is the primary source of this defence via antibiotic 2 
production, then a disturbance of the healthy coral microbiota may allow 3 
opportunistic infection (Lesser et al. 2007). Ritchie (2006) showed that bacteria 4 
associated with corals in a healthy state have greater antibiotic activity compared to 5 
those associated with stressed/diseased coral, thus the controls on development and 6 
maintenance of the natural microbiota may be important for coral health. Because the 7 
magnitude and frequency of stress on coral reef organisms are expected to increase in 8 
the future (Hoegh-Guldberg 1999), coral health might rely on how quickly their 9 
bacterial communities recover from disturbance and the stability and resilience of the 10 
natural community.  11 
 12 
Apprill et al. (2009) hypothesised that the primary method of acquisition of microbial 13 
associates by the coral was phagocytosis by the ectoderm, which is in closest contact 14 
with the seawater microbial community, a method utilised by other invertebrates 15 
(Foster 2005; Nussbaumer et al. 2006; Apprill et al. 2009). In contrast, in corals the 16 
most common mode for acquiring symbiotic algae is via phagocytosis by the 17 
gastroderm, where they then avoid digestion by preventing maturation of the 18 
phagosome (the fusion of the phagosome and lysome) (Marlow and Martindale 2007). 19 
Although both mechanisms may play a role in bacterial acquisition, Apprill et al. 20 
(2009) found no evidence of bacterial cells concentrated within the gastrodermal 21 
cavity of 76 h old coral planulae of the coral Pocillopora meandrina and Sharp et al. 22 
(2010), similarly found no evidence for direct transmission of bacteria from coral 23 
colonies of Acropora, Montipora and Diploria to their gametes, with bacteria not 24 
being detectable until settlement and subsequent metamorphosis. In healthy adult 25 
 5 
corals, Ainsworth and Hoegh-Guldberg (2009) showed that compartmentalised 1 
bacterial colonies of γ-proteobacteria frequently inhabited the gastrodermis, perhaps 2 
representing the host-species specific bacterial associates of corals found in several 3 
previous studies (Rohwer et al. 2002; Rohwer and Kelley 2004; Klaus et al. 2005). 4 
The ectodermal tissues were apparently devoid of bacteria, except when the host coral 5 
was exposed to environmental stress, after which extensive bacterial colonisation took 6 
place across both the cell layers (Ainsworth and Hoegh-Guldberg 2009). These 7 
studies therefore raise the question of where the coral-associated microbiota is located 8 
and how it is maintained. If so few bacteria are normally associated with the coral 9 
tissues, the majority must be resident in the coral surface mucus layer (SML) (Guppy 10 
and Bythell 2006; Kooperman et al. 2007; Sweet et al. 2011), or the underlying 11 
skeleton (Shashar et al. 1997; Fine et al. 2005). The rate and mechanism of turnover 12 
of the SML is largely unknown (Brown and Bythell 2005), but the bacterial 13 
communities of this layer may be expected to be much more transient than tissue-14 
associated bacteria, as well as more strongly influenced by passive settlement from 15 
the water column (Sweet et al. 2010). 16 
 17 
The importance of a natural healthy microbial community and subsequent microbial 18 
balance is readily appreciated when considering some of the deleterious results of 19 
antibiotic treatment in other biological systems. Several studies have shown the 20 
adverse effects of disturbing established microbial communities in a variety of 21 
systems but most notably in the human gut (Jernberg et al. 2007; Sekirov et al. 2008; 22 
Yap et al. 2008; Croswell et al. 2009). The effects of such a disturbance can cause 23 
prolonged (up to weeks in the human gut) disruption in otherwise stable functional 24 
group composition (Croswell et al. 2009; Sekirov et al. 2010) which have been linked 25 
 6 
to several human pathologies (Turnbaugh et al. 2006; Frank et al. 2007; Liu et al. 1 
2007; Penders et al. 2007). For most of these associations, however, it is not clear 2 
whether the microbial imbalance is a cause or an effect of the pathology. Diseases 3 
such as vaginal candidiasis and Clostridium difficile colitis frequently occur following 4 
a course of antibiotic therapy (Crogan and Evans 2007; Sobel 2007), which favours 5 
the hypothesis that the microbial community shift precedes the onset of the pathology. 6 
However, the generality of these processes in respect to other ecological systems is 7 
unknown.  8 
 9 
The ability of the coral or its associated microbes to be resilient to environmental 10 
stress (i.e. the ability of the microbial associates to return to their original community 11 
composition after disturbance), may have important implications in understanding 12 
disease dynamics and mechanisms of pathology in the coral (Bourne et al. 2009). The 13 
coral-algal symbiosis has been shown to be resilient, in that corals may be able to 14 
acquire more stress tolerant clades during periods of heightened temperatures, for 15 
example, but return to their previous clade composition after the event (Rowan 2004). 16 
Garren et al, (2009) similarly showed that the bacterial communities of corals exposed 17 
to fish farm effluents, took up the dominant bacteria present within the water column 18 
over the first 5 d, however within 22 d the original community had returned, 19 
suggesting that coral-microbial associates are highly resilient, despite changing 20 
environmental conditions. Whether the coral itself, its microbial associates or some 21 
combination of the two, is responsible for restoring the bacterial community as well as 22 
the effect of the frequency of disturbance remains to be understood. In this study, we 23 
used a broad-spectrum antibiotic, ciprofloxacin, in a 6 d treatment to reduce the 24 
natural microbiota associated with the reef building coral A. muricata and followed 25 
 7 
the community succession over time using culture-independent 16S rRNA gene 1 
techniques from 0 to 96 h after cessation of antibiotic treatment and return of the 2 
corals to their natural environment on the reef.  3 
 4 
MATERIALS AND METHODS 5 
 6 
Sample collection and experimental design 7 
 8 
All coral samples were collected from a single site on the reef flat at Heron 9 
Island, Great Barrier Reef, Australia (Sweet et al. 2010) during March 2009. Nubbins 10 
of ca 38 mm were collected from a single coral colony of A. muricata, to avoid 11 
within-species variability reported in coral-associated bacterial communities 12 
(Kvennefors et al. 2010). After collection, they were placed in a holding tank for 1 13 
day prior to treatment with antibiotics to allow for acclimatization. The nubbins were 14 
mounted using marine putty onto threaded polypropylene sleeves and screwed into 15 
place on perspex sheets. Three nubbins were used as controls at time of collection and 16 
another 3 were taken before antibiotic treatment after acclimatization to allow for any 17 
shift in bacterial community dynamics as a result of handling. A further control tank 18 
was set up with corals (n = 3) held in the same manner as the treated tank, without the 19 
administration of the antibiotic and were sampled two days (48 h) after redeployment 20 
on the reef. The corals to be used in the experiment were placed in a sterile, purpose-21 
built dosing tank, containing 7 l of filtered sea water (0.22 μm sterivex filter) for 2 22 
hour periods, two times a day (07:00 am and 19:00 pm) and the antibiotic 23 
Ciprofloxacin was administered at 40 µg / ml. (AUC24/Minimum Inhibitory 24 
Concentration (MIC) [area under the concentration–time curve over 24 h divided by 25 
 8 
the MIC] target of ҆125). The broad spectrum antibiotic, Ciprofloxacin belonging to 1 
the group Fluoroquinolones, was chosen because of its generic bactericidal properties. 2 
Its mode of action depends upon blocking bacterial DNA replication by binding itself 3 
to the enzyme DNA gyrase and inhibiting the unwinding of bacterial chromosomal 4 
DNA during and after replication. It would therefore likely target a wide range of 5 
coral associates and is unlikely have toxic effects on the host. The corals were treated 6 
two times within 24 h to account for the half life of the antibiotic (4-6 h) (Forrest et al. 7 
1993). A dosage reported to be high enough to affect a large proportion of families of 8 
bacteria known to be associated with corals such as Enterobacteriaceae and 9 
Pseudomonas (Forrest et al. 1993; Utrup et al. 2010). Between treatments, the corals 10 
were held in a 14 l wash tank’ with filtered seawater and a sterile aquarium pump to 11 
provide aeration and flow. The filtered water in the wash tank was changed three 12 
times over the six days of dosing (average of treatment length from numerous studies 13 
using Ciprofloxacin in other systems (Nix et al. 1987; Forrest et al. 1993; Ceran et al. 14 
2011)).  15 
 16 
After completion of the 6d antibiotic treatment, three nubbins were sampled (T = 0), 17 
then the remainder were returned to the reef prior to collection at 30 min, 1, 2, 4, 6, 8, 18 
12, 24, 48, 72 and 96 h. Each set (n = 3 per time period) of samples were stored in 8 19 
ml EtOH at -20 ºC until DNA extraction and analyses. In addition to these samples, 20 
sets of n = 2 nubbins were collected at each sampling time to be embedded into 21 
Technovit resin on site for histology. HOBO
® 
Pendant loggers (Onset, Massachusetts, 22 
USA) were used to log light intensity and temperature in situ at the collection site and 23 
within the treatment tanks and conditions within the tank simulated those out on the 24 
reef flat. Pulse Amplitude Modulation (PAM) measurement of dark-adapted yield 25 
 9 
(photosynthetic performance) of the symbiotic algae was also performed as a proxy of 1 
coral health, both in the field and before and after the use of the antibiotic to assess 2 
any effects of antibiotic treatment on the coral, particularly the symbiotic algae. No 3 
behavioural or visible colour changes were observed, with normal polyp flowering at 4 
night throughout the experiment. 5 
 6 
Changes in total abundance of bacteria: Fluorescence in situ hybridization 7 
 8 
For each time period the total abundance of bacteria was estimated using 9 
fluorescent in situ hybridisation (FISH). Samples were fixed, fluorescently labelled 10 
and sectioned following the protocols of Bythell et al. (2002), with the modification of 11 
an equimolar mix of three complementary ‘eubacterial’ probes EUB338. EUB338-II 12 
and EUB338-III (EUBMIX). Oligonucleotide probes were purchased from Interactiva 13 
(http://www.interactiva.de) with an aminolink C6/MMT at the 5’ end. Four probes 14 
were used: the ‘universal’ eubacterial probes EUB338 (5’-GCT GCC TCC CGT AGG 15 
AGT-3’), EUB338-II (5’- GCA GCC ACC CGT AGG TGT-3’), EUB338-III (5’-16 
GCT GCC ACC CGT AGG TGT-3’) and the ‘non-sense probe’ NONEUB (5’-ACT 17 
CCT ACG GGA GGC AGC-3’), which has the complementary sequence to EUB338 18 
and was used to determine non-specific binding of probe. The three eubacterial probes 19 
were used in an equimolar mix (EUBMIX), prepared at a final total concentration of 20 
50 ng µl
-1
 in hybridization buffer (180 µl 5 mol l
-1
 NaCl, 20 µl 1 mol
-1
 Tris-HCL pH 21 
7.5, 200 µl Boehringer blocking reagent for nucleic acid hybridisation, 40% 22 
formamide and 1 µl 10% SDS, made up to 1 ml with sterile distilled water) and the 23 
NONEUB probe was used singly (Bythell et al. 2002). 30 µl of either the EUBMIX or 24 
NONEUB probes were added to each tissue section.  25 
 10 
 1 
Sections were viewed under epiflourescence microscopy with an FITC-specific filter 2 
block (Nikon UK Ltd, Surrey, UK) and images recorded using an integrating camera 3 
(Model JVC KY-SSSB: Foster Findlay and Associates, Newcastle upon Tyne, UK). 4 
To count bacteria, an automatic cell counter (Cell C, (Selinummi et al. 2005)) that 5 
detects bacterial cells (0.0314 - 0.7 μm
2
) was used. Counts on 50 fields of view (FOV) 6 
were taken, scaled up to the total area of the coral nubbin and calculated to give an 7 
estimation of total bacterial abundance per cm
2 
of coral surface. The abundance of 8 
bacteria (total FISH counts) was compared across time periods with a one-way 9 
analysis of variance (MiniTab) as data was normally distributed and variances were 10 
equal. 11 
 12 
DGGE analysis 13 
 14 
All coral samples were crushed using sterile, autoclaved pestle and mortar and 15 
extracted using the QIAGEN DNeasy Blood and Tissue Kit; Spin column protocol. A 16 
portion of the bacterial 16S rRNA gene was amplified using standard prokaryotic 17 
(357F) (5´-CCTACGGGAGGCAGCAG-3´) and (518R) (5’-18 
ATTACCGCGGCTGCTGG-3’) primers. The GC – rich sequence 5’-CGC CCG CCG 19 
CGC GCG GCG GGC GGG GCG GGG GCA GCA CGG GGG G-3’ was 20 
incorporated in the forward primer 357 at its 5’ end to prevent complete disassociation 21 
of the DNA fragments during DGGE. All reactions were performed using a Hybaid 22 
PCR Express thermal cycler. PCR reaction mixture and programme was performed as 23 
in (Sweet et al. 2010). PCR products were verified by agarose gel electrophoresis 24 
[1.6% (w/v) agarose] with ethidium bromide staining and visualized using a UV 25 
 11 
transilluminator. DGGE was performed using the D-Code universal mutation 1 
detection system (Bio-Rad). PCR products were resolved on 10% (w/v) 2 
polyacrylamide gels that contained a 30–60% denaturant gradient for 13 h at 60°C 3 
and a constant voltage of 50 V. Gels were stained with 9µl Sybr Gold (Sigma) in 50µl 4 
of TAE for 20 min then washed in 500ml 1X TAE for a further 30 min then visualized 5 
using a UV transilluminator. Bands of interest (those which explained the greatest 6 
differences/similarities between samples) were excised from DGGE gels, left 7 
overnight in Sigma molecular grade water, vacuum centrifuged, re-amplified with 8 
primers 357F and 518R, labelled using Big Dye (Applied biosystems) transformation 9 
sequence kit and sent to Genevision (Newcastle University UK) for sequencing. 10 
Bacterial operational taxonomic units (OTUs) (Guppy and Bythell 2006) were defined 11 
from DGGE band-matching analysis using Bionumerics 3.5 (Applied Maths BVBA). 12 
Standard internal marker lanes were used to allow for gel-to-gel comparisons. 13 
Tolerance and optimisation for band-matching was set at 1 %.  14 
 15 
Image processing, gel-to-gel standardisation and band-matching of DGGE 16 
image profiles using BioNumerics allows comparison between different 17 
environmental samples, however the process does not detect all bands visible on the 18 
gel, hence underestimating amplicon diversity. To overcome this, both the DGGE 19 
profiles (corrected for gel-to-gel variations) and the multidimentional scaling (MDS) 20 
analysis of the BioNumerics band intensity data have been shown. A one way analysis 21 
of similarity (ANOSIM, PRIMER vs 6), was performed on untreated coral nubbins 22 
present within the holding tank after handling and those direct from the field to test 23 
for effects of handling. A one-way permutation analysis of variance (PERMANOVA, 24 
PRIMER, (Anderson 2001)) based on Bray-Curtis similarities was performed to test 25 
 12 
differences between the bacterial 16S rRNA gene assemblages associated with the 1 
antibiotic treated corals. Pairwise comparisons based on permutation were conducted 2 
to test differences among each combination of time period after treatment (Anderson 3 
2001). This approached was used because multivariate data was not normal but 4 
variances were still equal. A non metric multidimensional scaling (NMDS) was used 5 
to represent six time intervals after antibiotic exposure on a 2-D plot. A similarity of 6 
profile analysis (SIMPROF, PRIMER Clark and Warwick, 2001) was performed to 7 
determine true clusters which were then overlaid upon the NMDS (Clarke and 8 
Warwick 2001). An analysis of contribution to similarities (SIMPER, PRIMER) was 9 
performed to determine which 16S rRNA gene ribotypes best explained dissimilarities 10 
among sample types that were statistically different.   11 
 12 
Clone Libraries and ARDRA screening 13 
 14 
Almost-complete 16S rRNA gene fragments were amplified from the DNA 15 
extracted using the universal eubacterial 16S rRNA gene primers pA, (5’-AGA GTT 16 
TGA TCG TGG CTC AG-3’) and pH, (5’-AAG GAG GTG ATC CAG CCG CA-3’). 17 
Ten PCR cycles were performed at 94º C for 1 min, 55º C for 1 min and 72º C for 3 18 
min then a further twenty five cycles at 94º C for 1 min, 53º C for 1 min and 72º C for 19 
3 min with a final extension at 72º C for 10 min. The amplified products were purified 20 
using the Qiagen PCR purification kit, inserted into the pGEM-T vector system 21 
(Promega) and transformed into Escherichia coli JM109 cells. A total of 196 clones 22 
containing the 16S rRNA gene inserts were randomly selected from each sample (n = 23 
1; field control, tank control, t = 30, 4 h and 96 h), and boiled lysates were prepared 24 
from each by mixing a picked clone in 30 μl of TE and boiled for 3 min followed by 25 
 13 
-CTA AAA 1 
CGA CGG CCA GT- -CAG GAA ACA GCT ATG AC- . 2 
Twenty five PCR cycles were performed at 94º C for 1 min, 55º C for 1 min and 72º 3 
C for 1 min with a final extension at 72º C for 10 min. The products were then 4 
digested with the restriction enzymes Hae111 and Rsa1 (Promega) (4 µg of PCR 5 
product, 2 µl of restriction buffer, 0.2 µl of BSA, 0.07 µl OF Hae111, 0.1 ul of Rsa1 6 
and made up to 20 µl with sigma water for 2 hours at 37 º C then 10 min at 67 ºC). 7 
Restriction fragments were resolved by 3 % agarose gel electrophoresis, visualized 8 
using a UV transilluminator and grouped based on restriction patterns. 9 
Representatives from each group were sequenced. Closest match of retrieved 10 
sequences was determined by RDP 11 similarity matching (Cole et al. 2009). 11 
 12 
RESULTS 13 
 14 
Effects of antibiotics on total coral bacterial abundance and coral health 15 
 16 
As there were no significant differences (ANOSIM, p = 0.81) in bacterial 17 
diversity between field samples and those left to acclimatise in the tanks, all 18 
comparison were made between antibiotic treatments and the field-collected samples, 19 
which are hereafter referred to as ‘healthy’ samples. There was a significant (99.97%) 20 
reduction in abundance of bacteria between ‘healthy’ samples and those immediately 21 
following antibiotic treatment ‘T=0’ (ANOVA df = 9, F = 428.5 p = 0.001), 22 
demonstrating effectiveness of the antibiotic treatment. There was no significant trend 23 
over time in dark-adapted yield (Fv/Fm) of the symbiotic algae, which was used as a 24 
proxy for coral health in this case (Ralph et al. 2005; Hill and Ralph 2007) 25 
 14 
(Regression ANOVA. df = 34, F = 0.70, p = 0.409, Fv/Fm ranging from 0.6-0.7, see 1 
supplementary material Fig 1). Coupled with a complete lack of mortality, morbidity, 2 
any observed changes in behaviour (e.g. polyp expansion and/or retraction) and 3 
pigmentation of the treated corals, the results indicated that there was little or no 4 
adverse affect of the treatment on the host coral. Mean bacterial abundance
 
on healthy 5 
corals collected from the field was 8.1
 
± 0.2 x 10
8 
cells cm
-2
 (± SD), which was 6 
reduced to 2.6
 
± 0.6 x 10
5
 cells cm
-2
 (± SD) immediately after treatment. Bacterial 7 
populations started to recover within 12 h (Fig 2). Although total bacterial abundance 8 
tended to recover over time, after 96 h of redeployment, corals had not fully regained 9 
the pre-treatment bacterial abundance (Tukey’s p < 0.05).
 
Thus in this case, recovery 10 
of the coral to its normal bacterial population densities would take over 4 days.  11 
 12 
Effects of antibiotics on 16S rRNA gene bacterial diversity 13 
  14 
DGGE profiles changed significantly immediately following antibiotic 15 
administration (PERMANOVA, f = 3.41, df = 6, p = 0.001, Fig 3), with no significant 16 
effects of nubbin handling without treatment (ANOSIM, p = 0.81). Over 55% of the 17 
variability recorded in bacterial assemblages between different samples was explained 18 
by temporal changes after ciprofloxacin treatment, while 45% was related to 19 
variability among replicates. This indicates that responses and recovery of bacterial 20 
communities to antibiotic exposure was highly variable between nubbins of a single 21 
coral colony. Post hoc comparisons showed significant differences in bacterial 22 
assemblages between each time period, the only exception being found for the 8-12 h 23 
period which showed high levels of variation between replicates (Table 1).  24 
 25 
 15 
DGGE analysis showed that not all bacteria were eliminated after antibiotic treatment, 1 
as several bands were still present in the gel immediately after treatment, although 2 
overall ribotype richness (S) was greatly reduced (Fig 3). This indicates that some 3 
bacteria present in corals have resistance to ciprofloxacin. Patterns of DGGE banding 4 
(Fig 3) revealed a diverse microbial community associated with control samples, this 5 
microbial assemblage becoming significantly less diverse after treatment 6 
(PERMANOVA, t = 2.19, p = 0.009 Fig. 3,4a, Table 1) and the number of bands 7 
shown in the DGGE increased again following treatment when nubbins were 8 
deployed back into their natural habitat.  9 
 10 
Sequences identified from dominant bands of the DGGE included ribotypes similar to 11 
Sphingobacterium sp. (AF260710), Endozoicomonas sp. (FJ202766) and 12 
Hydrogenophaga sp. (FM955626) that were conspicuous on control nubbins but 13 
disappeared following treatment, indicating a high susceptibility of these bacteria to 14 
ciprofloxacin (Fig. 4b-d, Table 2). While Sphingobacterium sp. (AF 2600710) 15 
recovered quickly from the antibiotic effect (8-12 h), Endozoicomonas sp. (FJ202766) 16 
and Hydrogenophaga sp. (FM 955626), were more sporadic in their resettlement, 17 
showing more significant recovery at later stages after 2-4 days (Fig 4b-d, Table 3), 18 
although in one replica Endozoicomonas sp. did recover within the same time frame 19 
as Sphingobacterium sp. Ribotypes from both γ and α proteobacteria appeared to be 20 
primary colonizers, becoming more abundant between 0-4 h after treatment; however, 21 
the former remained up to the 4 day sample period, whereas the later were eliminated 22 
after 12 h (Fig. 4e, g, Table 2). Therefore, both γ and α proteobacteria were successful 23 
at colonizing the coral, but γ proteobacteria were able to retain the occupied space for 24 
longer. Ribotypes closely related to Flavobacteria sp. (AB294989) appeared to be 25 
 16 
later colonizers as they were absent in control nubbins and only became abundant 2-4 1 
days after antibiotic application (Fig. 4h, Table 3). A ribotype closely related to a 2 
Clostridium sp., a well known pathogenic microorganism in the human gut, was 3 
present in control nubbins, apparently resisted the antibiotic treatment and increased 4 
its abundance 0-4 h after redeployment (Fig. 4f, Table 3), indicating that potential 5 
pathogens, such as this may be part of the normal microbiota of the coral, only 6 
increasing their abundance when the normal coral microbiota is disrupted.  7 
 8 
Clone libraries generally supported the DGGE results, showing 16S rRNA gene 9 
ribotypes in the healthy coral to be more diverse overall but with a relatively small 10 
number of dominant bacterial ribotypes. 16S rRNA gene ribotypes in the field control 11 
samples (‘healthy’) and those in the tank controls were similar in diversity and 12 
abundance, suggesting handling and husbandry during the treatment of the corals had 13 
no effect on their microbial communities. There were only a few ribotypes 14 
(EU919223, AB254287 and DQ665793) present in low abundance in the tank 15 
controls which were not detected in the field controls, however these did not appear in 16 
any of the other samples either. Ribotypes closely related to a Roseobacter sp. 17 
(DQ985046) (15.2% abundance, Table 3) and a Sphingobacterium sp. (AF260710) 18 
(12.2%) dominated the total abundance of clone libraries with a further 54% 19 
(FJ347758, DQ200474, DQ200446, EU919132 and EU919205) belonging to a 20 
distinct group within the γ--proteobacteria. Only one ribotype amongst this group has 21 
been named to genus and species level and represents a recently discovered genus, 22 
Endozoicomonas. These dominant genera were all reduced in frequency after 23 
treatment, but gradually recovered over time after deployment onto the reef (Table 3). 24 
There were a number of low frequency ribotypes in the healthy coral that were 25 
 17 
eliminated by treatment (Table 3) and failed to recover within the timeframe of the 1 
experiment. A small number of ribotypes, either in low abundance in healthy coral 2 
(EU909941, HM153430 and CP000568) or absent in healthy coral and established 3 
following treatment (EU600663, FJ887948, GQ502581, AY632498, AB249868 and 4 
EU330363), that became dominant immediately after treatment. All these ribotypes 5 
either returned to the low frequencies found in the healthy coral within 96 h or were 6 
completely eliminated. The only exception was a ribotype similar to Flavobacteria sp. 7 
(EU600663) which established itself and increased in dominance following treatment, 8 
remaining highly dominant at the end of the experiment (96 h).   9 
 10 
DISCUSSION 11 
 12 
Bacterial assemblages associated with A. muricata displayed complex 13 
responses to antibiotic treatment. While some coral-associated bacteria were highly 14 
resistant to ciprofloxacin, a large majority were eliminated and bacterial abundance 15 
was reduced by 99.97%, therefore the treatment represented a significant ecological 16 
disturbance to the coral-associated microbiota. Colonization of newly opened niches 17 
within the coral host started within the first 4 h after treatment and redeployment on 18 
the reef, but neither bacterial population densities nor the diversity of the natural 19 
‘healthy’ microbial community fully recovered within 4 days. Thus, our results 20 
demonstrate that the process of re-colonisation in A. muricata was a relatively slow 21 
process, despite high rates of mucus production (Wild et al. 2004) and rapid flow rates 22 
reported for Acroporas at the study site. A relatively slow recovery of the normal 23 
microbiota following disturbances has important implications for coral health, which 24 
has been shown to depend in part on stress-related shifts of highly specific coral-25 
microbial associations (Frias-Lopez et al. 2003; Pantos et al. 2003; Jokiel and Coles 26 
 18 
2004; Sutherland et al. 2004; Bourne 2005; Williams and Miller 2005; Gil-Agudelo et 1 
al. 2007; Rosenberg et al. 2007; Mydlarz et al. 2009). The rate of natural disturbance 2 
in coral-microbial communities is unknown, but results shown here, suggests that 3 
competition and interaction between bacteria may be an important process 4 
maintaining the healthy microbial community.  5 
 6 
Re-settlement of bacteria in A. muricata started with a rapid colonization of 16S 7 
rRNA gene ribotypes similar to Actinobacterium sp., Bacteroidetes sp., 8 
Pseudoalteromonas sp., Flavobacterium sp. and an α-proteobacterium previously 9 
identified in the water column at our study site (Kvennefors et al. 2010; Sweet et al. 10 
2010). Waterborne ribotypes only became abundant when the coral-associated 11 
bacteria such as ribotypes similar to Sphingobacteria, Chloroflexi and numerous γ-12 
proteobacteria were either eliminated completely or their abundance significantly 13 
reduced by the antibiotic treatment, highlighting the potential importance of 14 
opportunistic microbial invasions for the coral’s microbial dynamics after a 15 
disturbance event. Similar results were found by Garren et al, (2009) where corals 16 
transplanted into waters exposed to fish farm effluents incorporated ribotypes present 17 
in the water column at the new site, however the original community structure was 18 
shown to recover after 22 d. In this study, these opportunistic bacterial ribotypes were 19 
typically reduced in abundance or completely eliminated after 96 h, with only one 20 
ribotype (a Flavobacteria sp.) remaining dominant thereafter. Thus, our results 21 
support Garren et al, (2009), showing a similar, strong resilience in bacterial 22 
community structure following perturbation. 23 
 24 
 19 
In most cases, bacteria that are available in the immediate environment (e.g. the water 1 
column) opportunistically colonized the coral but were replaced relatively quickly by 2 
the regular microbiota. Many marine bacteria present in the ‘healthy’ coral microbiota 3 
are known to show induction or enhancement of antibiotic production in the presence 4 
of opportunistic bacteria like those found within the water column (Burgess et al. 5 
1999; Slattery et al. 2001; Trischman et al. 2004). Recent studies have also shown that 6 
antagonism of certain species plays an important part in regulating the dynamics of 7 
coral-associated microbial communities (Rypien et al. 2010).In this study, both α- and 8 
γ-proteobacteria were successful at colonizing the coral at 4-8 h post-treatment with 9 
the latter found to persist for longer. The case of the Flavobacteria sp. suggests that 10 
relatively few bacteria are able to persist after the normal microbiota returns. Whether 11 
this represents a novel and stable bacterial introduction made possible by the 12 
disturbance, or whether it takes longer than 96 h for this ribotype to be eliminated, 13 
remains to be determined.  14 
 15 
Potentially pathogenic bacteria such as a ribotype closely related to Clostridium sp. 16 
were shown to increase when the coral microbiota was disturbed. In our experiment, 17 
this bacterium was originally found in corals collected from the field, showing 18 
resistance to antibiotic treatment and becoming dominant in the coral assemblage in 19 
less than 8 h after treatment. This is consistent with the results of Garren et al, (2009), 20 
where members of the Clostridiales as well as Desulfovibrio sp., which were both 21 
absent from the surrounding water column, increased in abundance under disturbance 22 
(Garren et al. 2009). Sequences affiliated with Clostridium sp. have been associated 23 
with black band disease (Frias-Lopez et al. 2002) and White Plague (Sunagawa et al. 24 
2009) in corals and are commonly part of mixed-pathogen infections in a variety of 25 
 20 
terrestrial organisms, producing toxins and necrosis in animal tissues (Lawley et al. 1 
2009). One particular species of this genus, Clostridium difficile is implicated in 2 
antibiotic-associated disease of the human gut system (Goldenberg et al. 2010; Koo et 3 
al. 2010). C. difficile is considered to be unable to compete successfully in the normal 4 
intestinal ecosystem, but can compete when the normal biota is disturbed by 5 
antibiotics (Thelestam and Chaves-Olarte 2000; Keel and Songer 2007; 6 
Papatheodorou et al. 2010). Clostridium sp. reported in this study may be acting 7 
similarly to Vibrio sp. which are known to be opportunistic, only becoming abundant 8 
when the coral becomes stressed (Ben-Haim et al. 2003; Rosenberg and Falkovitiz 9 
2004; Geffen et al. 2009; Nissimov et al. 2009; Rypien et al. 2010; Tait et al. 2010). 10 
However in this study, no vibrios were detected. There is therefore growing evidence 11 
that potential pathogens may be present within ‘healthy’ coral microbial communities, 12 
but are actively controlled by the coral holobiont, only becoming prevalent following 13 
disturbance (Lesser et al. 2007). For corals, the production of compounds capable of 14 
inhibiting bacterial growth is vital for resisting and surviving opportunistic infections 15 
(Ritchie 2006; Hayashida-Soiza et al. 2008; Geffen et al. 2009; Mao-Jones et al. 16 
2010), however, this study shows that this natural antibacterial activity is clearly 17 
taxon-specific, with the broad-spectrum ciprofloxacin treatment eliminating >99% of 18 
the coral-associated bacterial load. In addition to this, other mechanisms are likely to 19 
prevent and/or regulate invasion of competitors or potential pathogens. Some of these 20 
mechanisms include growth rate of natural non-pathogenic microbiota, nutrient 21 
uptake pathways and spatial heterogeneity in bacterial abundance (Rypien et al. 2010). 22 
Conversely, potential pathogens such as V. harveyi have recently been shown to 23 
inhibit quorum sensing, potentially giving this species a competitive advantage that 24 
allows it to proliferate during periods of high temperature (Tait et al. 2010). Given 25 
 21 
that healthy corals are continually exposed to potentially pathogenic bacteria (Rypien 1 
et al. 2010), it is imperative to better understand the underlying processes and 2 
mechanisms of maintenance of the ‘healthy’ coral-associated microbial community. 3 
Finally, given that over half of the microbial community associated with corals is 4 
believed to be Archaea (Wegley et al. 2004; Kellogg et al. 2004), future work should 5 
include analysis of this group to better understand their role in health and disease.   6 
 7 
In conclusion, this study shows that initial settlement of bacteria upon the coral is 8 
rapid, occurring within minutes to hours after disturbance. Nevertheless, recovery of 9 
the initial microbial assemblage, in both abundance and diversity, requires longer 10 
periods than might be expected given high mucus production rates for this coral 11 
species. Bacterial succession will rely on specific interactions among early colonizers 12 
and the surviving coral microbiota which might facilitate and/or prevent the 13 
establishment of later colonizers (Ritchie and Smith 2004; Ritchie 2006). Potential 14 
pathogens inhabit the coral tissue at low abundances, only becoming prevalent when 15 
the natural microbiota is altered by a disturbance. The persistent and (at four days) 16 
incremental changes in some bacteria in response to this disturbance provides 17 
important insights into the controls that normally regulate community structure in the 18 
coral ‘holobiont’.    19 
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Figure legends 2 
 3 
Figure 1. Dark-adapted photosynthetic yields (Fv/Fm) obtained using pulse amplitude 4 
modulated (PAM) fluorometry. Used as a measure to detect sublethal physiological 5 
changes in symbiotic algae of the coral during antibiotic treatment. No significant 6 
changes were detected over the course of the experiment (Regression ANOVA. df = 7 
34, F = 0.70, p = 0.409).  8 
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Figure 2. Mean bacterial abundance (cm
-2
) of n = 3 replicates of resin-embedded 1 
corals taken at all time periods. UnT = untreated coral nubbins. Error bars represent 2 
standard errors.  3 
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 28 
Figure 3. 16S rRNA gene fingerprints (DGGE) of coral samples in relation to time 1 
following treatment and pre-treatment controls. Composite DGGE image standardised 2 
for gel-to-gel comparison using BioNumerics. S value represents total number of 3 
bands detected by BioNumerics within the average of sample replicates. 4 
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Figure 4. Multidimensional scaling (MDS) analysis of DGGE profiles based on 1 
BioNumerics analysis of relative band intensities. (a) MDS plot showing similarities 2 
(Bray Curtis similarity) between samples. C = Untreated ‘control’ corals, 0 = etc., (b - 3 
g) Relative abundances of a subset of specific bacteria overlaid as bubble plots on the 4 
MDS plot shown in (a). Size of bubble represents relative density of the DGGE band 5 
of that particular bacterial sequence within individual samples.  6 
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Table 1 Pairwise tests of PERMANOVA showing differences in bacterial 16S rRNA 1 
gene diversity from DGGE analysis between untreated (healthy) corals (C) and 2 
antibiotic treated coral samples. 0 = directly after treatment with ciprofloxacin. 3 
 4 
 5 
Time      t P(perm)  perms
C, 0 2.1886 0.009 126
C, up to 4 h 1.8993 0.01 400
C, 8 to 12 h 1.2315 0.1568 418
C, 1 d 1.9665 0.027 56
C, 2 d 1.6928 0.045 21
C, 4 d 2.0862 0.0579 21
0, up to 4 h 1.9246 0.006 209
0, 8 to 12 h 2.2256 0.006 208
0, 1 d 2.3208 0.03 35
0, 2 d 2.2848 0.006 21
0, 4 d 2.7493 0.006 21
up to 4 h, 8 to 12 h 1.8751 0.003 411
up to 4 h, 1 d 2.0706 0.015 84
up to 4 h, 2 d 1.5892 0.04 28
up to 4 h, 4 d 2.0514 0.035 28
8 to 12 h, 1 d 1.4306 0.038 84
8 to 12 h, 2 d 1.2241 0.2118 28
8 to 12 h, 4 d 1.4318 0.0699 28
1 d, 2 d 1.3478 0.042 84
1 d, 4 d 1.9227 0.038 84
2 d, 4 d 1.5953 0.021 84  6 
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Table 2: Relative contribution (%) of bacterial ribotypes sequenced from bands excised 1 
from the DGGE gel to total ribotype diversity, based on SIMPER analysis of DGGE band 2 
intensities, indicating the average contribution of each bacterial ribotype to the similarity 3 
within each grouping factor (pre-treatment controls (FC) or time period following 4 
treatment). Ribotypes were identified according to closest matches identified by BLAST 5 
analysis. The species identity, group affiliation, GenBank accession number and % 6 
sequence identity of the closest match are shown. 7 
 8 
Band No. Species ID (closest relative) Group affiliation GenBank Accession No.
(% match) FC 0 up to 4 h 8 - 12 h 1 day 2 days 4 days
4 Chloroflexi sp. Chloroflexi EU909941 (97%) 3.04
7 Pseudidiomarina sp. γ-proteobacteria FJ887948 (99%) 1.93
8 Nocardiodes sp. Actinobacteria FJ406568 (99%) 8.31 11.7 18.31 4.67
9 Sphingobacterium sp. Sphingobacteria AF260710 (67%) 12.22 14.89 12.31 12 42.95
10 Unknown Unknown Unknown 2.61
11 Pseudoalteromonas sp. γ-proteobacteria EU330363 (99%) 5.86
12 Unknown Unknown Unknown 4.05
13 Unknown Unknown Unknown 3.6 12.82
14 γ-proteobacterium γ-proteobacteria GU118719 (99%) 7.17
15 Actinobacterium Actinobacteria AY632498 (92%) 4.06 4.59 1.96
16 α-proteobacterium α-proteobacteria AB254287 (99%) 2.41 28.99 4.97
17 ε-proteobacterium ε-proteobacteria HM318989 (99%) 2.36 10.72 7.67 15.18
18 Hydrogenophaga sp. β-proteobacteria FM955626 (83%) 7.95 4.72 13.93
19 Unknown Unknown Unknown 5.7
20 Clostridium sp. Clostridia CP000568 (100%) 1.71 15.65 2.56 1.96 9.07
21 Rhodobacteraceae sp. α-proteobacteria FJ202776 (99%) 7.16 12.76 9.4
22 Flavobacteria sp. Flavobacteria EU600663 (100%) 10.18 2.92
23 Bacteroidetes sp. Bacteroidetes AB254287 (100%) 2.8 8.92
24 Firmicutes sp. Firmicutes GQ502581 (87%) 4.54 9.92 10.13
25 β-proteobacteria β-proteobacteria AF419359 (100%) 1.95 4.17
26 γ proteobacterium γ-proteobacteria GU230328 (95%) 6.37
27 Endozoicomonas sp. γ-proteobacteria FJ809457 (97%) 4.08 13.14 9.82
28 γ proteobacterium γ-proteobacteria EU919132 (99%) 4.31 18.56 16.61 9.95 12.42 18.32
29 Pseudoalteromonas sp γ-proteobacteria FM163075 (99%) 2.15 9.84 13.89
30 Flavobacteria sp. Flavobacteria AB294989 (100%) 7.58 11.62 14.95
31 Endozoicomonas sp. γ-proteobacteria GU184761 (99%) 1.22
32 Stenotrophomonas sp γ-proteobacteria HM153430 (97%) 1.12 12.69
35 α-proteobacteria α-proteobacteria FJ718457 (96%) 10.74
36 Unknown Unknown Unknown 9.95 10.14
38 Unknown Unknown Unknown 2.81
41 Marinobacter sp. γ-proteobacteria HM141532 (98%) 4.67
43 Unknown Unknown Unknown 3.96
Contribution % (to community similatrity)
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Table 3: Heatmap-table summarizing the relative abundance (%) of dominant 1 
bacterial sequence affiliations for 16S rRNA gene clone libraries. Sequences were 2 
blasted against GenBank and the Ribosomal Database Project (RDP11) for closest 3 
match to Genus level. 0 signifies that clones related to that sequence were not detected 4 
in the sample (n = 196). ******** signifies sequence to short to acquire a Genbank 5 
accession number. FC = Field controls taken at time of sampling; TC = tank controls, 6 
kept in tanks, untreated and returned onto the reef; time periods = duration redeployed 7 
back onto the reef after treatment 8 
 9 
GenBank Acq. No. Genus Group Best match (isolate) FC TC 30 min 4 h 96 h
HQ180154 Marinobacter sp. γ-proteobacteria HM141532 (98%) 3.4 2 0 0 0
HQ180166 Marinobacter sp. γ-proteobacteria HM141524 (99%) 1.3 0.8 0 0 0
HQ180147 Endozoicomonas sp. γ-proteobacteria GU118776 (97%) 1 1 0 0 0
HQ180156 Spongiobacter sp. γ-proteobacteria FJ457274 (97%) 0.8 1 0 0 0
HQ180158 Hydrogenophaga sp. β-proteobavteria DQ413154 (99%) 0.1 1.2 0 0 0
HQ180164 Unknown γ-proteobacteria DQ200430 (95%) 2 3 0 0 0
HQ180145 Endozoicomonas sp. γ-proteobacteria GU118779 (89%) 0.3 1 0 0 0
 HQ180162 Unknown ε-proteobacteria AF367482 (98%) 0.4 1 0 0 0
HQ180144 Endozoicomonas sp. γ-proteobacteria DQ200474 (94%) 5 2 0 3 4
HQ180161 Endozoicomonas sp. γ-proteobacteria DQ200474 (95%) 10 10.8 6 6.3 6.7
HQ180155 Roseobacter sp. α-proteobacteria DQ985046 (97%) 15.2 11.2 4.6 6 10.2
HQ180149 Pedobacter sp. Sphingobacteria AJ438174 (97%) 12.2 13.4 1.3 4.2 18.1
HQ180146 Endozoicomonas sp. γ-proteobacteria FJ347758 (99%) 12.1 10 5.7 18 19
HQ180143 Endozoicomonas sp. γ-proteobacteria EU919205 (98%) 10 9.7 5 7 9
HQ180160 Endozoicomonas sp. γ-proteobacteria DQ200446 (95%) 4 6 0 1 1.9
HQ180140 Endozoicomonas sp. γ-proteobacteria DQ200474 (97%) 3 1.5 0 1 1
HQ180141 Endozoicomonas sp. γ-proteobacteria DQ200474 (96%) 8.2 10 4.2 9 9
HQ180163 Unknown γ-proteobacteria DQ204262 (99%) 3.2 2 0 2.1 3
HQ180142 Endozoicomonas sp. γ-proteobacteria EU919132 (100%) 2 2.4 0 0 0.2
******** Clostridium sp. Clostridia CP000568 (100%) 1.7 2 14.6 2.6 1
HQ180153 Stenotrophomonas sp. γ-proteobacteria HM153430 (97%) 0.8 1 7.7 0 0
HQ180165 Stenotrophomonas sp. γ-proteobacteria AF137357 (98%) 0.3 0.8 5 0 0
HQ180150 Pseudoalteromonas sp. γ-proteobacteria EU330363 (99%) 0 0 5 10.7 0
HQ180151 Iamia sp. Actinobacteria AJ581606 (97%) 0 0 2 3.5 0
HQ180157 Nocardioides sp. Actinobacteria AF408943 (95%) 0 0 8.6 2.4 0
HQ180159 Ureaplsma sp. Firmicutes GQ502581 (95%) 0 0 8 6 0
HQ180148 Pseudidiomarina sp. γ-proteobacteria DQ118948 (100%) 0 0 9 5 0
HQ180167 Chloroflexus sp. Chloroflexi EU909941 (97%) 3 4.2 8 2 2
HQ180152 Flavobacteria sp. Flavobacteria EU600663 (100%) 0 0 5.3 10.2 14.9
JF272000 Aeromonas sp. γ-proteobacteria EU919223 (100%) 0 0.8 0 0 0
JF272001 Pseudoalteromonas sp. γ-proteobacteria AJ391202 (99%) 0 0.2 0 0 0
JF272002 Pseudoalteromonas sp. γ-proteobacteria DQ665793 (100%) 0 1 0 0 0  10 
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